Biotech NewsBiogen Expands Immunology Portfolio with Strategic Acquisition BioTech Health XMay 23, 2024 Biogen Inc. has announced the acquisition of Human Immunology Biosciences (HI-Bio) for an upfront payment of $1.15 billion,… 0 Shares 0 0 0 0 0 0 0
Biotech NewsFDA Approves Biosimilars Yesafili and Opuviz, Opening New Avenues for Affordable Eye Treatments BioTech Health XMay 21, 2024 The FDA has recently approved two new biosimilars, Yesafili (aflibercept-jbvf) by Biocon Biologics and Opuviz (aflibercept-yszy) by Samsung… 0 Shares 0 0 0 0 0 0 0